metastatic Breast cancer
It is called the prognosis.
The area on the spinal cord affected by transverse myelitis will determine the individual's level of functioning. The higher-up the lesion, the greater the disability.
While subjective, "fair" indicates a moderate probability of returning to normal function - it's not great odds, but the risk of severe complications or death is low.
Successful treatment of Helicobacter pylori has improved morbidity and mortality rates.the prognosis for PUD,with proper treatment and avoidance of causative factors, is excellent.Morbidity and mortality are higher in patients with secondary ulcers.
Stage FIGO grade 3 refers to a classification used in the staging of gynecological cancers, particularly endometrial cancer. In this context, FIGO (International Federation of Gynecology and Obstetrics) grade 3 indicates a high-grade tumor that exhibits marked cellular atypia and a higher likelihood of aggressive behavior. It typically signifies that the cancer has a poorer prognosis compared to lower-grade tumors, emphasizing the need for more intensive treatment and monitoring.
Pure choriocarcinoma of the testis represents the most aggressive pathologic variant of germ cell tumors in adults, characteristically with early hematogenous and lymphatic metastatic spread. Because of early spread and inherent resistance to anticancer drugs the prognosis is poor. Mixed choriocarcinoma is treatable. Ask you doctor questions like this.
The prognosis for embryonal carcinoma and choriocarcinoma cells in testicular cancer is generally favorable, especially when detected early. These tumors are considered aggressive but are highly responsive to chemotherapy, which significantly improves survival rates. With appropriate treatment, the overall cure rate for testicular cancer, including those with these cell types, exceeds 90%. Regular follow-up and monitoring are essential to manage any potential recurrence.
Because 75% of all esophagectomy patients and 100% of all esophagogastrectomy patients will have metastatic disease, morbidity and mortality rates for these procedures are high.
A-T is a fatal condition. Children with A-T become physically disabled by their early teens and typically die by their early 20s, usually from the associated blood cancers and malignancies
Doctors test bone marrow and scrap bones to diagnose and monitor cancers, particularly hematologic malignancies like leukemia and lymphoma. Bone marrow contains blood-forming cells, and analyzing it can reveal abnormal cell growth or the presence of cancerous cells. Scraping bones may also help identify metastatic cancer or assess the extent of disease. These tests provide crucial information for treatment planning and prognosis.
Prognosis Pro = prior or before Gnosis = knowledge
Metastasis, the spread of cancer from its original site to other parts of the body, is often challenging to cure. While some metastatic cancers can be managed effectively through treatments like chemotherapy, radiation, or targeted therapies, the prognosis varies significantly depending on factors like cancer type, stage, and individual patient circumstances. In some cases, certain metastatic cancers may be controlled for extended periods, but a complete cure remains elusive for many. Ongoing research continues to explore new therapeutic approaches to improve outcomes for patients with metastatic disease.
The prognosis of abulia depends on the prognosis of the underlying condition.
Metastatic liver cancer, where cancer has spread to the liver from another part of the body, is a challenging condition to treat, and the prognosis varies depending on several factors. Survival rates are generally lower for metastatic liver cancer than for primary liver cancer. Here are some key factors that influence the prognosis: Cancer Type: The type of cancer that has spread to the liver plays a significant role. Some primary cancers, such as colorectal cancer, are more responsive to treatment than others. Extent of Spread: The number and size of liver tumors, as well as whether the cancer has spread to other organs, affect the prognosis. Extensive liver involvement or metastasis to multiple organs can make treatment more challenging. Liver Function: The overall health and function of the liver are crucial. If the liver is severely damaged by cancer, cirrhosis, or other factors, it can limit treatment options and affect survival. General Health: The patient's overall health, age, and ability to tolerate treatment are important. Stronger, healthier individuals may have better outcomes. Response to Treatment: Some individuals respond well to treatment, including chemotherapy, targeted therapy, immunotherapy, or surgical interventions. A positive response to treatment can extend survival. Treatment Approach: Treatment options for metastatic liver cancer can include surgery, chemotherapy, radiation therapy, targeted therapy, immunotherapy, or a combination of these. The choice of treatment and how well it works influence the prognosis. It's essential for individuals with metastatic liver cancer to consult with an oncologist or a medical specialist to discuss their specific case and receive personalized treatment recommendations. While metastatic liver cancer is often challenging to cure, treatments can help manage the disease, improve quality of life, and extend survival. The goal of treatment may shift from curing the cancer to controlling its growth and providing symptom relief. Survival rates and expected outcomes can vary widely from person to person, so it's essential to have an open and honest discussion with a healthcare provider to understand the individual prognosis and make informed decisions about treatment and care.
Prognosis
a prognosis is the result after treating the disease
Prognosis is the noun.